학술논문
682P Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S543-S543
Subject
Language
ISSN
0923-7534